Shanghai - Delayed Quote CNY
Dizal (Jiangsu) Pharmaceutical Co., Ltd. (688192.SS)
57.21
-0.22
(-0.38%)
As of 10:28:48 AM GMT+8. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
389,637.24
91,288.64
--
10,285.45
27,760.81
Cost of Revenue
9,200.18
3,214.75
--
9,007.99
24,298.69
Gross Profit
380,437.06
88,073.89
--
1,277.46
3,462.11
Operating Expense
1,304,727.88
1,212,369.81
786,186.41
666,177.31
763,827.56
Operating Income
-924,290.82
-1,124,295.92
-786,186.41
-664,899.85
-760,365.44
Net Non Operating Interest Income Expense
-18,466
-3,976.26
-1,851.76
-892.91
1,478.88
Pretax Income
-928,339.85
-1,107,611.93
-735,742.48
-669,875.91
-586,583.47
Tax Provision
71.26
101.32
260.61
--
28.42
Net Income Common Stockholders
-837,224.19
-1,107,713.25
-736,003.09
-669,875.91
-586,611.89
Basic EPS
-2.04
-2.72
-1.82
-1.86
-1.63
Diluted EPS
-2.04
-2.72
-1.82
-1.86
-1.63
Basic Average Shares
411,241.21
407,247.52
404,397.30
360,148.34
359,884.60
Diluted Average Shares
411,241.21
407,247.52
404,397.30
360,148.34
359,884.60
Total Operating Income as Reported
-929,742.81
-1,107,611.93
-735,742.48
-669,875.91
-586,583.47
Rent Expense Supplemental
--
--
--
227.92
2,622.63
Total Expenses
1,313,928.06
1,215,584.56
786,186.41
675,185.30
788,126.25
Net Income from Continuing & Discontinued Operation
-837,224.19
-1,107,713.25
-736,003.09
-669,875.91
-586,611.89
Normalized Income
-848,075.30
-1,124,299.05
-767,649.16
-670,847.98
-735,743.36
Interest Income
2,405.53
3,641.42
2,526.16
2,259.84
1,535.40
Interest Expense
18,522.04
7,573.97
4,343.13
3,068.17
--
Net Interest Income
-18,466
-3,976.26
-1,851.76
-892.91
1,478.88
EBIT
-909,817.80
-1,100,037.96
-731,399.35
-666,807.74
-760,365.44
EBITDA
-909,817.80
-1,034,455.02
-672,971.55
-613,083.25
-730,546.34
Reconciled Cost of Revenue
9,200.18
3,214.75
--
9,007.99
24,298.69
Reconciled Depreciation
--
65,582.94
58,427.80
53,724.49
29,819.10
Net Income from Continuing Operation Net Minority Interest
-837,224.19
-1,107,713.25
-736,003.09
-669,875.91
-586,611.89
Total Unusual Items Excluding Goodwill
14,468.14
22,114.39
42,194.76
972.07
198,841.95
Total Unusual Items
14,468.14
22,114.39
42,194.76
972.07
198,841.95
Normalized EBITDA
-924,285.95
-1,056,569.41
-715,166.31
-614,055.32
-929,388.29
Tax Rate for Calcs
0
0
0
--
0
Tax Effect of Unusual Items
3,617.04
5,528.60
10,548.69
--
49,710.49
12/31/2020 - 12/10/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade